Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
-
67862
- 01
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Eli Lilly (Suisse) SA - Retsevmo 40 mg, gélules
Swissmedic Registration
67862
Sequence
01
Product name
Retsevmo 40 mg
Description
gélules
ATC-Classification
L01EX22
ATC-Description
Selpercatinib
Introduction of Sequence
08.02.2021
Composition
Capsule: selpercatinibum 40 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, E 171, E 172 (nigrum), encre: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Galenic Form
Capsules
Active Agent
Dose
additional_information
Selpercatinibum
40 mg
Capsule
BAG: Active Agent
Dose
Selpercatinibum
40 mg
Inactive agents
additional_information
(Nigrum)
Cellulosum Microcristallinum
E 171
color.
E 172
color.
Gelatina
matériel de la capsule
Kalii Hydroxidum
Lacca
encre
Pro Capsula
Propylenglycol
Silica Colloidalis Anhydrica
Package number
Package Size
EFP
CP
Category
SL
Out of trade (MedRef)
004
56
1958.87
2146.80
A
SL
Yes
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home